Giorgio Milazzo

8PUBLICATIONS
69CO-AUTHORS
Molecular targetsCancer geneticsNeurology and neuromuscular diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 02, 2025
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.

Ruby Pandher, Chengyuan Xue, Laura D Gamble

|Jul 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

Jayne E Murray, Emanuele Valli, Giorgio Milazzo

|Mar 29, 2023
MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma Cells.

Piergiuseppe De Rosa, Federica Severi, Suleman Khan Zadran

|Dec 23, 2022
Single-Cell Sequencing Identifies Master Regulators Affected by Panobinostat in Neuroblastoma Cells.

Giorgio Milazzo, Giovanni Perini, Federico M Giorgi

|Dec 10, 2021
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs.

Roberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi

|Apr 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.

Laura D Gamble, Stefania Purgato, Michelle J Henderson

Pageof 2

Frequent Collaborators

5 joint publications

Murray D Norris

4 joint publications

Michelle Haber

3 joint publications

Piergiuseppe De Rosa

3 joint publications

Laura D Gamble